Effectiveness of complementary and self-help treatments for anxiety disorders

Medical Journal of Australia

Volumn 181, Issue 7 SUPPL., 2004, Pages

  Jorm, Anthony F ^a   Christensen, Helen ^a   Griffiths, Kathleen M ^a,b   Parslow, Ruth A ^a   Rodgers, Bryan ^a   Blewitt, Kelly A ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b Depression/Anxiety Consumer Res U   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; ASCORBIC ACID; AYURVEDIC DRUG; CALCIUM; CARBIDOPA; CENTELLA ASIATICA EXTRACT; CHINESE DRUG; CLOMIPRAMINE; CYCLOSPORIN; CYMBOPOGON CITRATUS EXTRACT; DIAZEPAM; DIGOXIN; GINGER EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; HOMEOPATHIC AGENT; HYPERICUM PERFORATUM EXTRACT; INOSITOL; KAVA EXTRACT; MAGNESIUM; OXAZEPAM; PASSIFLORA INCARNATA EXTRACT; PLACEBO; PLANT EXTRACT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALERIAN; VITAMIN B GROUP; WARFARIN;

ACUPUNCTURE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ALTERNATIVE MEDICINE; ANXIETY DISORDER; AUTOGENIC TRAINING; CLINICAL TRIAL; COCHRANE LIBRARY; DIET RESTRICTION; DIET THERAPY; DRUG INHIBITION; EDEMA; EVIDENCE BASED MEDICINE; EXERCISE; GENERALIZED ANXIETY DISORDER; HUMAN; HUMOR; HYDROTHERAPY; HYPOTENSION; LIFESTYLE; LIVER FAILURE; MASSAGE; MEDICAL LITERATURE; MEDITATION; MEDLINE; META ANALYSIS; MOVEMENT THERAPY; MUSIC THERAPY; OBSESSIVE COMPULSIVE DISORDER; PANIC; PHOBIA; PREMATURE LABOR; PSYCINFO; RELAXATION TRAINING; RELIGION; REVIEW; SELF HELP; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; YOGA;

EID: 5044250704     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb06352.x     Document Type: Review

References (271)

1. Andrews G, Hall W. The mental health of Australians. Canberra: Mental Health Branch, Australian Government Department of Health and Aged Care, 1999.
2. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. Canberra: Australian Institute of Health and Welfare, 1999.
3. Goldberg D. Plato versus Aristotle: categorical and dimensional models for common mental disorders. Compr Psychiatry 2000; 41 (2 Suppl 1): 8-13.
4. National Health Committee. Guidelines for assessing and treating anxiety disorders. Wellington: NHC, 1998.
5. Issakidis C, Andrews G. Service utilisation for anxiety in an Australian community sample. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 153-163.
6. Jorm AF, Medway J, Christensen H, et al. Public beliefs about the helpfulness of interventions for depression: effects on actions taken when experiencing anxiety and depression symptoms. Aust N Z J Psychiatry 2000; 34: 619-626.
7. MacLennan AH, Wilson DH, Taylor AW. The escalating cost and prevalence of alternative medicine. Prev Med 2002; 35: 166-173.
8. Jorm AF, Christensen H, Griffiths KM, Rodgers B. Effectiveness of complementary and self-help treatments for depression. Med J Aust 2002: 176 (10 Suppl): S84-S96.
9. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1998; 37 (10 Suppl): 27S-45S.
10. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with p+osttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 1998; 37 (10 Suppl): 4S-26S.
11. American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. Work group on panic disorder. Am J Psychiatry 1998; 155 (5 Suppl): 1-34.
12. Bernstein GA, Shaw K. Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 1997; 36 (10 Suppl): 69S-84S.
13. Department of Health. Treatment choice in psychological therapies and counselling - evidence based clinical practice guideline. London: Department of Health, 2001.
14. Foa EB, Davidson JRT, Frances A. The expert consensus guideline series. Treatment of posttraumatic stress disorder. J Clin Psychiatry 1999; 60 Suppl 16: 3-76.
15. Foa EB, Keane TM, Friedman MJ. Guidelines for treatment of PTSD. J Trauma Stress 2000; 13: 539-588.
16. Institute for Clinical Systems Improvement. Health care guideline: major depression, panic disorder and generalised anxiety disorder in adults in primary care. Bloomington: ICSI, 2001.
17. National Department of Health. Standard treatment guidelines and essential drugs list for South Africa: adult hospital level. Pretoria: South African Department of Health, 1998.
18. Royal Australian and New Zealand College of Psychiatrists Clnical Practice Guidelines Team for Panic Disorder and Agoraphobia. Australian and New Zealand clinical practice guidelines for treatment of panic disorder and agoraphobia. Aust N Z J Psychiatry 2003; 37: 641-656.
19. World Health Organization. WHO guide to mental health in primary care. London: Royal Society of Medicine, 2000.
20. Andrews G, Crino R, Hunt C, et al. The treatment of anxiety disorders: clinician's guide and patient manuals. 1st ed. New York: Cambridge University Press, 1994.
21. Fugh-Berman A, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychasom Med 1999; 61: 712-728.
22. Muskin PR, editor. Complementary and alternative medicine and psychiatry. Washington, DC: American Psychiatric Association, 2000.
23. Nathan PE, Gorman JM, editors. A guide to treatments that work. New York: Oxford University Press, 1998.
24. Wong AH, Smith M, Boon HS. Herbal remedies in psychiatric practice. Arch Gen Psychiatry 1998; 55: 1033-1044.
25. National Health and Medical Research Council. How to use the evidence: assessment and application of scientific evidence. Canberra: NHMRC, 2000.
26. Armstrong NC, Ernst E. A randomized, double-blind placebo-controlled trial of a Bach Flower remedy. Complement Ther Nurs Midwifery 2001; 7: 215-221.
27. Walach H, Rilling C, Engelke U. Efficacy of Bach-Flower remedies in test anxiety: a double-blind, placebo-controlled, randomized trial with partial crossover. J Anxiety Disord 2001; 15: 359-366.
28. Carroll D, Ring C, Suter M, Willemsen G. The effects of an oral multivitamin combination with calcium, magnesium, and zinc on psychological well-being in healthy young male volunteers: a double-blind placebo-controlled trial. Psychopharmacologia 2000; 150: 220-225.
29. Topic B, Hasenohrl RU, Hacker R, Huston JP. Enhanced conditioned inhibitory avoidance by a combined extract of Zingiber officinale and Ginkgo biloba. Phytother Res 2002; 16: 312-315.
30. Mantani R, Cimino A. A primer of complementary and alternative medicine and its relevance in the treatment of mental health problems. Psychiatr Q 2002; 73: 367-381.
31. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998; 158: 2200-2211.
32. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo or ginseng: nature of the evidence. Ann Pharmacother 2000; 34: 1478-1482.
33. Bradwejn JC, Zhou Y, Koszycki D, Shlik JA. Double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. J Clin Psychopharmacol 2000; 20: 680-684.
34. Chen HC, Hsieh MT, Lai E. Studies on the suanzaorentang in the treatment of anxiety. Psychopharmacology (Berl) 1985; 85: 486-487.
35. Mills PJ, Farag NH, Newton RP, Parry BL. Effects of a traditional herbal supplement on anxiety in patients with generalized anxiety disorder. J Clin Psychopharmacol 2002; 22: 443-444.
36. Panijel M. Treatment of moderately severe anxiety states. Therapiewoche 1985; 35: 4659-4668.
37. Bourin M, Bougerol T, Guitton B, Broutin E. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundam Clin Pharmacol 1997; 11: 127-132.
38. Slonim D, White K. Homeopathy and psychiatry. J Mind Behav 1983; 4: 401-410.
39. Fisher P. How does homeopathy work: are we looking in the right place? Homeopathy 2003; 92: 1-2.
40. Cialdella F, Boissel JP, Belon P. Homeopathic specialities as substitutes for benzodiazepines: double-blind vs placebo study. Therapie 2001; 56: 397-402.
41. McCutcheon LE. Treatment of anxiety with a homeopathic remedy. J Applied Nutr 1996; 48: 2-6.
42. Benjamin J, Agam G, Levine J, et al. Inositol treatment in psychiatry. Psychopharmacol Bull 1995; 31: 167-175.
43. Benjamin J, Levine J, Fux M, et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 1995; 152: 1084-1086.
44. Palatnik A, Frolov K, Fux M, Benjamin J. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. J Clin Psychopharmacol 2001; 21: 335-339.
45. Fux M, Levine J, Aviv A, Belmaker RH. Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry 1996; 153: 1219-1221.
46. Fux M, Benjamin J, Belmaker RH. Inositol versus placebo augmentation of serotonin reuptake inhibitor in the treatment of obsessive-compulsive disorder: a double-blind cross-over study. Int J Neuropsychopharmacol 1999; 2: 193-195.
47. Kaplan Z, Amir M, Swartz M, Levine J. Inositol treatment of posttraumatic stress disorder. Anxiety 1996; 2: 51-52.
48. Cairney S, Maruff P, Clough AR. The neurobehavioural effects of kava. Aust N Z J Psychiatry 2002; 36: 657-662.
49. Pittler MH, Ernst E. Kava extract for treating anxiety [Cochrane Review]. The Cochrane Library, Issue 1, 2003.
50. Bilia AR, Gallon S, Vincieri FF. Kava-kava and anxiety: growing knowledge about the efficacy and safety. Life Sci 2002: 70: 2581-2597.
51. Leite JR, Seabra M de L, Maluf E, et al. Pharmacology of lemongrass (Cymbopogon citratus Stapf). III. Assessment of eventual toxic, hypnotic and anxiolytic effects on humans. J Ethnopharmacol 1986; 17: 75-83.
52. Duke JA. Novel psychotherapeutic drugs: a role for ethnobotany: commentary. Psychopharmacol Bull 1995: 31: 177-184.
53. Simon W, Edwards RV. Glycyrrhiza (licorice) in the treatment of psychiatric illness. J Clin Exp Psychopathol 1957; 18: 79-86.
54. Olukoga A, Donaldson D. Liquorice and its health implications. J R Soc Health 2000; 120: 83-89.
55. Strandberg TE, Anderssen S, Jarvenpaa AL, McKeigue PM. Preterm birth and licorice consumption during pregnancy. Am J Epidemiol 2002; 156: 803-805.
56. Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology 1990: 23: 79-81.
57. Bockova E, Hronek J. Kolomaznik M, et al. Potentiation of the effects of anxiolytics with magnesium salts. Cesk Psychiatr 1992; 88: 141-144.
58. Bilia R, Bergonzi MC. Gallori S, et al. Stability of the constituents of Calendula, milk thistle and passionflower tinctures by LC-DAD and LC-MS. J Pharm Biomed Anal 2002; 30: 613-624.
59. Akhondzadeh S, Naghavi HR, Vazirian M, et al. Passionflower in the treatment of generalised anxiety: a pilot double-blind randomised controlled trial with oxazepam. J Clin Pharm Ther 2001; 26: 363-367.
60. Nathan P. The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L). Mol Psychiatry 1999; 4: 333-338.
61. Taylor LH, Kobak KA. An open-label trial of St. John's Wort (Hypericum perforatum) in obsessive-compulsive disorder. J Clin Psychiatry 2000; 61: 575-578.
62. Davidson JR, Connor KM. St. John's Wort in generalized anxiety disorder: three case reports. J Clin Psychopharmacol 2001; 21: 635-636.
63. Dominguez RA. Valerian: its value as a sedative hypnotic. In: Mischoulon D, Rosenbaum JF. editors. Natural medications for psychiatric disorders: considering the alternatives, 1st ed. Philadelphia: Lippincott Williams and Wilkins, 2002: 132-146.
64. Andreatini R, Sartori VA, Seabra ML, Leite JR. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother Res 2002; 16: 650-654.
65. Kohnen R, Oswald D. The effects of valerian, propranolol. and their combination on activation, performance, and mood of healthy volunteers under social stress conditions. Pharmacopsychiatry 1988; 21: 447-448.
66. Willey LB, Mady SP, Cobaugh DJ. Wax PM. Valerian overdose: a case report. Vet Hum Toxicol 1995: 37: 364-365.
67. Yager J, Siegfreid SL, DiMatteo TL. Use of alternative remedies by psychiatric patients: illustrative vignettes and a discussion of the issues. Am J Psychiatry 1999: 156: 1432-1438.
68. Wong AH, Smith M, Boon HS. Herbal remedies in psychiatric practice. Arch Gen Psychiatry 1998; 55: 1033-1044.
69. Mischoulon D, Rosenbaum JF, editors. Natural medications for psychiatric disorders: considering the alternatives, 1st ed. Philadelphia: Lippincott Williams and Wilkins, 2002.
70. Reifenberg E. On a case of obsessive-compulsive neurosis significantly improved with ascorbic acid. Psychiatr Neurol Med Psychol (Leipz) 1954: 5: 161-167.
71. Westenberg HG, den Boer JA, Kahn RS. Psychopharmacology of anxiety disorders: on the role of serotonin in the treatment of anxiety states and phobic disorders. Psychopharmacol Bull 1987; 23: 145-149.
72. Kahn RS, Westenberg HG, Verhoeven WM, et al. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int Clin Psychopharmacol 1987; 2: 33-45.
73. 2 induced panic. Int J Neuropsychopharmacol 2000: 3 Suppl 1: 272.
74. Kahn RS, Westenberg HG. L-5-Hydroxytryptophan in the treatment of anxiety disorders. J Affect Disord 1985; 8: 197-200.
75. Blier P, Bergeron R. Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder: preliminary findings. Int Clin Psychopharmacol 1996; 11: 37-44.
76. Larzelere MM, Wiseman P. Anxiety, depression, and insomnia. Prim Care 2002; 29: 339-360.
77. Cauffield JS, Forbes HJ. Dietary supplements used in the treatment of depression, anxiety, and sleep disorders. Lippincotts Prim Care Pract 1999; 3: 290-304.
78. US Food and Drug Administration. Information paper on L-tryptophan and 5-hydroxy-L-tryptophan, February 2001. Available at: vm.cfsan.fda.gov/~dms/ds-tryp1.html (accessed Mar 2004).
79. Guizhen L, Yunjun Z, Linxiang G, Aizhen L. Comparative study on acupuncture combined with behavioral desensitization for treatment of anxiety neuroses. Am J Acupunct 1998; 26: 117-120.
80. Spector IP, Carey MP, Jorgensen RS, et al. Cue-controlled relaxation and "aromatherapy" in the treatment of speech anxiety. Behav Cognit Psychother 1993; 21: 239-253.
81. Cooke B, Ernst E. Aromatherapy: a systematic review. Br J Gen Pract 2000; 50: 493-496.
82. Levine BA. Use of hydrotherapy in reduction of anxiety. Psychol Rep 1984; 55: 526.
83. Field TM. Touch therapies. In: Hoffman RR. Sherrick MF, Warm JS, editors. Viewing psychology as a whole: the integrative science of William N Dember. 1st ed. New York: American Psychological Association, 1998: 603-624.
84. Vickers A, Zollman C. ABC of complementary medicine: massage therapies. BMJ 1999; 319: 1254-1257.
85. Field T, Seligman S, Scafidi F, Schanberg S. Alleviating posttraumatic stress in children following Hurricane Andrew. J Appl Dev Psychol 1996; 17: 37-50.
86. Field T, Grizzle N, Scafidi F, Schanberg S. Massage and relaxation therapies' effects on depressed adolescent mothers. Adolescence 1996; 31: 903-911.
87. Field T, Ironson G, Scafidi F, et al. Massage therapy reduces anxiety and enhances EEC pattern of alertness and math computations. Int J Neurosci 1996: 86: 197-205.
88. Shulman KR, Jones GE. The effectiveness of massage therapy intervention on reducing anxiety in the workplace. J Appl Behav Sci 1996: 32: 160-173.
89. Richards KC, Gibson R, Overton-McCoy AL. Effects of massage in acute and critical care. AACN Clin Issues 2000; 11: 77-96.
90. Stetter F, Kupper S. Autogenic training: a meta-analysis of clinical outcome studies. Appl Psychophysiol Biofeedback 2002; 27: 45-98.
91. Scogin F, Bynum J, Stephens G, Calhoon S. Efficacy of self-administered treatment programs: meta-analytic review. Prof Psychol - Res Pract 1990; 21: 42-47.
92. Gould RA, Clum GA, Shapiro D. The use of bibliotherapy in the treatment of panic: a preliminary investigation. Behav Ther 1993; 24: 241-252.
93. Marrs RW. A meta-analysis of bibliotherapy studies. Am J Community Psychot 1995; 23: 843-870.
94. Newman MG, Erickson T, Przeworski A, Dzus E. Self-help and minimal-contact therapies for anxiety disorders: is human contact necessary for therapeutic effect? J Clin Psychol 2003; 59: 271-274.
95. Ritter M, Low KG. Effects of dance/movement therapy: a meta-analysis. The Arts in Psychotherapy 1996; 23: 249-260.
96. Kline F, Burgoyne RW, Staples F, et al. A report on the use of movement therapy for chronic, severely disabled outpatients. Art Psychother 1977; 4: 181-183.
97. Brooks D, Stark A. The effect of dance/movement therapy on affect: a pilot study. Am J Dance Ther 1989; 11: 101-112.
98. Erwin-Grabner T, Goodill SW, Hill ES, Von Neida K. Effectiveness of dance/movement therapy on reducing test anxiety. Am J Dance Ther 1999: 21: 19-34.
99. Kubota N. An analysis of the therapeutic process of Dosa therapy. Dissertation Abstracts International 2001; 61: 3352.
100. Kuettel TJ. Affective change in dance therapy. Am J Dance Ther 1982; 5: 56-64.
101. Leste A, Rust J. Effects of dance on anxiety. Percept Mot Skills 1984; 58: 767-772.
102. Tkachuk GA, Martin GL. Exercise therapy for patients with psychiatric disorders: research and clinical implications. Prof Psychol - Res Pract 1999: 30: 275-282.
103. Dunn AL, Trivedi MH, O'Neal HA. Physical activity dose-response effects on outcomes of depression and anxiety. Med Sci Sports Exerc 2001; 33 Suppl: 587-597.
104. Petruzzello SJ, Landers DM, Hatfield BD, et al. A meta-analysis on the anxiety-reducing effects of acute and chronic exercise. Outcomes and mechanisms. Sports Med 1991; 11: 143-182.
105. Stich FA. A meta-analysis of physical exercise as a treatment for symptoms of anxiety and depression [dissertation]. Madison: University of Wisconsin, 1998.
106. Steptoe A, Edwards S, Moses J, Mathews A. The effects of exercise training on mood and perceived coping ability in anxious adults from the general population. J Psychosom Res 1989; 33: 537-547.
107. McEntee DJ, Halgin RP. Cognitive group therapy and aerobic exercise in the treatment of anxiety. J Coll Student Psychother 1999; 13: 37-55.
108. Broocks A, Bandelow B, Pekrun G, et al. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry 1998; 155: 603-609.
109. Martinsen EW, Hoffart A, Solberg OY. Aerobic and non-aerobic forms of exercise in the treatment of anxiety disorders. Stress Med 1989; 5: 115-120.
110. Manger TA. The effects of a community-based aerobic exercise program on posttraumatic stress disorder-related symptoms and concomitant anxiety and depression [dissertation]. Hempstead, NY: Hofstra University, 2000.
111. Ventis WL, Higbee G, Murdock SA. Using humor in systematic desensitization to reduce fear. J Gen Psychol 2001; 128: 241-253.
112. Abel MH. Interaction of humor and gender in moderating relationships between stress and outcomes. J Psychol 1998; 132: 267-276.
113. Yovetich NA, Dale JA, Hudak MA. Benefits of humor in reduction of threat-induced anxiety. Psychol Rep 1990; 66: 51-58.
114. Ascough JC, Ettinger RF, Nelson DA. Humour, anxiety and task performance. J Pers Soc Psychol 1971; 19: 243-246.
115. Thomas D, Abbas KA. Comparison of transcendental meditation and progressive relaxation in reducing anxiety. BMJ 1978; 2: 1749.
116. Lehrer PM, Woolfolk RL, Rooney AJ, et al, Progressive relaxation and meditation. A study of psychophysiological and therapeutic differences between two techniques. Behav Res Ther 1983; 21: 651-662.
117. Raskin M, Bali LR, Peeke HV. Muscle biofeedback and transcendental meditation. A controlled evaluation of efficacy in the treatment of chronic anxiety. Arch Gen Psychiatry 1980; 37: 93-97.
118. Wilson HB. The specific effects model: relaxation and meditation effects on cognitive and somatic anxiety [dissertation]. Athens, Ohio: Ohio University, 2000.
119. Boswell PC, Murray EJ. Effects of meditation on psychological and physiological measures of anxiety. J Consult Clin Psychol 1979; 47: 606-607.
120. Kirkland K, Hollandsworth JG. Effective test taking: skills-acquisition versus anxiety-reduction techniques. J Consult Clin Psychol 1980; 48: 431-439.
121. Shannahoff-Khalsa DS, Ray LE, Levine S, et al. Randomized controlled trial of yogic meditation techniques for patients with obsessive-compulsive disorder. CNS Spectr 1999; 4: 34-47.
122. Morse DR. An exploratory study of the use of meditation alone and in combination with hypnosis in clinical dentistry. J Am Soc Psychosomatic Dent Med 1977; 24: 113-120.
123. Morse DR, Cohen BB. Desensitization using meditation-hypnosis to control "needle" phobia in two dental patients. Anesth Prog 1983; 30: 83-85.
124. Russell LA. Comparisons of cognitive, music, and imagery techniques on anxiety reduction with university students. J Coll Student Dev 1992; 33: 516-523.
125. Stanton HE. A comparison of the effects of an hypnotic procedure and music on anxiety level. Aust J Clin Exp Hypn 1984; 12: 127-132.
126. Wu SM. Effects of music therapy on anxiety, depression and self-esteem of undergraduates. Psychologica 2002; 45: 104-114.
127. Stoudenmire J. A comparison of muscle relaxation training and music in the reduction of state and trait anxiety. J Clin Psychol 1975; 31: 490-492.
128. Kerr T, Walsh J, Marshall A. Emotional change processes in music-assisted reframing. J Music Ther 2001; 38: 193-211.
129. Razali SM, Hasanah CI, Aminah K, Subramaniam M. Religious-sociocultural psychotherapy in patients with anxiety and depression. Aust N Z J Psychiatry 1998; 32: 867-872.
130. Snaith P. Meditation and psychotherapy. Br J Psychiatry 1998; 173: 193-195.
131. Gould RA, Otto MW, Pollack MH, Yap L. Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: a preliminary meta-analysis. Behav Ther 1997; 28: 285-305.
132. Boswell PC, Murray EJ. Effects of meditation on psychological and physiological measures of anxiety. J Consult Clin Psychol 1979; 47: 606-607.
133. Lehrer PM, Atthowe JM, Webber ESP. Effects of progressive relaxation and autogenic training on anxiety and physiological measures, with some data on hypnotizability. In: McGuigan FJ, Sime WE, Wallace JM, editors. Stress and tension control. New York: Plenum, 1980: 171-181.
134. Hillenberg JB, Collins FL. The importance of home practice for progressive relaxation training. Behav Res Ther 1983; 21: 633-642.
135. Flanders P, McNamara JR. Relaxation training and home practice in the treatment of anxiety. Psychol Rep 1987; 61: 819-822.
136. Cragan MK, Deffenbacher JL. Anxiety management training and relaxation as self-control in the treatment of generalized anxiety in medical outpatients. J Counseling Psychol 1984; 31: 123-131.
137. DeBerry S, Davis S, Reinhard KE. A comparison of meditation-relaxation and cognitive/behavioural techniques for reducing anxiety and depression in a geriatric hospital. J Geriatr Psychiatry 1989; 22: 231-247.
138. Tarrier N, Main CJ. Applied relaxation training for generalised anxiety and panic attacks: the efficacy of a learnt coping strategy on subjective reports. Br J Psychiatry 1986; 149: 330-336.
139. Carlson CR, Collins FL Jr, Nitz AJ, et al. Muscle stretching as an alternative relaxation training procedure. J Behav Ther Exp Psychiatry 1990; 21: 29-38.
140. O'Neill LM, Barnier AJ, McConkey K. Treating anxiety with self-hypnosis and relaxation. Contemp Hypn 1999; 16: 68-80.
141. Barlow DH, Rapee RM, Brown TA. Behavioural treatment of generalised anxiety disorder. Behav Ther 1992; 23: 551-570.
142. Borkovec TD, Costello E. Efficacy of applied relaxation and cognitive-behavioural therapy in the treatment of generalised anxiety disorder. J Consult Clin Psychol 1993; 61: 611-619.
143. Ost LG, Breitholtz E. Applied relaxation vs. cognitive therapy in the treatment of generalized anxiety disorder. Behav Res Ther 2000; 38: 777-790.
144. Kumaraiah V. Treatment of anxiety through GSR biofeedback and progressive muscular relaxation. Indian J Clin Psychol 1979; 6: 209-211.
145. Hutchings DF, Denney DR, Basgall J, Houston BK. Anxiety management and applied relaxation in reducing general anxiety. Behav Res Ther 1980; 18: 181-190.
146. LeBoeuf A, Lodge JA. A comparison of frontalis EMG feedback training and progressive relaxation in the treatment of chronic anxiety. Br J Psychiatry 1980; 137: 279-284.
147. Rupert PA, Dobbins K, Mathew RJ. EMG biofeedback and relaxation instructions in the treatment of chronic anxiety. Am J Clin Biofeedback 1981; 4: 52-61.
148. Pitkin GL. An investigation of cognitive and relaxation-imagery techniques on college students' level of general anxiety [dissertation]. Pullman: Washington State University, 1983.
149. Bouchard SJ. Effects of a self-administered subliminal-relaxation treatment on anxiety [dissertation]. San Diego, Calif: United States International University, 1984.
150. DeBerry S. An evaluation of progressive muscle relaxation on stress related symptoms in a geriatric population. Int J Aging Hum Dev 1981; 14: 255-269.
151. Walker LS, Busby K, Walker JL. The differential effects of progressive relaxation and imagery on anxiety. Can J Counselling 1987; 21: 207-215.
152. Rowe GL. The effects of matching individual anxiety response patterns to treatment [dissertation]. Pullman: Washington State University, 1991.
153. Kohli A, Varma VK, Nehra R. Comparison of efficacy of psychorelaxation and pharmacotherapy in generalized anxiety disorder. J Pers Clin Stud 2000; 16: 43-48.
154. Gould RA, Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 1995; 15: 819-844.
155. Ost LG, Jerremalm A, Jansson L. Individual response patterns and the effects of different behavioural methods in the treatment of agoraphobia. Behav Res Ther 1984; 22: 697-707.
156. Ost LG. Applied relaxation: description of a coping technique and review of controlled studies. Behav Res Ther 1987; 25: 397-409.
157. McNamee G, O'Sullivan G, Lelliott PT, Marks I. Telephone-guided treatment for housebound agoraphobics with panic disorder: exposure vs. relaxation. Behav Ther 1989; 20: 491-497.
158. Michelson L, Mavissakalian M, Marchione K. Cognitive, behavioural and psychophysiological treatments of agoraphobia: a comparative outcome investigation. Behav Ther 1988; 19: 97-120.
159. Barlow DH, Craske MG, Cerny JA, Klosko JS. Behavioural treatment of panic disorder. Behav Ther 1989; 20: 261-282.
160. Ost LG, Westling BE, Hellstron K. Applied relaxation, exposure in vivo and cognitive methods in the treatment of panic disorder with agoraphobia. Behav Res Ther 1993; 31: 383-394.
161. Marks IM, Swinson RP, Basoglu M, et al. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. Br J Psychiatry 1993; 162: 776-787.
162. Clark DM, Salkovskis PM, Hackmann A, et al. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 1994; 164: 759-769.
163. Beck JG, Stanley MA, Baldwin LE, et al. A comparison of cognitive therapy and relaxation training for panic disorder. J Consult Clin Psychol 1994; 62: 818-826.
164. Ost LG, Westling BE. Applied relaxation vs. cognitive behaviour therapy in the treatment of panic disorder. Behav Res Ther 1995; 33: 145-158.
165. Arntz A, van den Hout M. Cognitive therapy vs. applied relaxation. Behav Res Ther 1996; 34: 113-121.
166. Van Etten ML, Taylor S. Comparative efficacy of treatments for PTSD: a meta-analysis. Clin Psychol Psychother 1998; 5: 126-145.
167. Silver SM, Brooks A, Obenchain J. Treatment of Vietnam War veterans with PTSD: a comparison of eye movement desensitization and reprocessing, biofeedback, and relaxation training. J Trauma Stress 1995; 8: 337-342.
168. Vaughan K, Armstrong MS, Gold R, et al. A trial of eye movement desensitization compared with image habituation training and applied muscle relaxation in post-traumatic stress disorder. J Behav Ther Exp Psychiatry 1994; 25: 283-291.
169. Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord 1996; 10: 185-199.
170. Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam war veterans. J Clin Psychol 1997; 53: 917-923.
171. Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry 1998; 55: 317-325.
172. Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol 2003; 71: 330-338.
173. Hatton AY. Anxiety sensitivity, perfectionism and risk-taking: a therapeutic intervention for obsessive-compulsive disorder [dissertation]. Columbia: University of South Carolina, 1999.
174. Fals-Stewart W, Marks AP, Schafer J. A comparison of behavioral group therapy and individual therapy in treating obsessive-compulsive disorder. J Nerv Ment Dis 1993; 181: 189-193.
175. Marks IM, Hodgson R, Rachman S. Treatment of chronic obsessive-compulsive neurosis by in-vivo exposure. A two-year follow-up and issues in treatment. Br J Psychiatry 1975; 127: 349-364.
176. Greist JH, Marks IM, Baer L, et al. Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry 2002; 63: 138-145.
177. Ost LG, Jerremalm A, Johansson J. Individual response patterns and the effects of different behavioural methods in the treatment of social phobia. Behav Res Ther 1981; 19: 1-16.
178. Jerremalm A, Jansson L, Ost LG. Cognitive and physiological reactivity and the effects of different behavioral methods in the treatment of social phobia. Behav Res Ther 1986; 24: 171-180.
179. Fedoroff IC, Taylor S. Psychological and pharmacological treatments of social phobia: a meta-analysis. J Clin Psychopharmacol 2001; 21: 311-324.
180. Miller MP, Murphy PJ, Miller TP. Comparison of electromyographic feedback and progressive relaxation training in treating circumscribed anxiety stress reactions. J Consult Clin Psychol 1978; 46: 1291-1298.
181. Jerremalm A, Jansson L, Ost LG. Individual response patterns and the effects of different behavioural methods in the treatment of dental phobia. Behav Res Ther 1986; 24: 587-596.
182. Vassend O, Willumsen T, Hoffart A. Effects of dental fear treatment on general distress. The role of personality variables and treatment method. Behav Modif 2000; 24: 580-599.
183. Berggren U, Hakeberg M, Carlsson SG. Relaxation vs. cognitively oriented therapies for dental fear. J Dent Res 2000; 79: 1645-1651.
184. Willumsen T, Vassend O, Hoffart A. A comparison of cognitive therapy, applied relaxation, and nitrous oxide sedation in the treatment of dental fear. Acta Odontol Scand 2001; 59: 290-296.
185. Bedell JR, Archer RP, Rosmann M. Relaxation therapy, desensitization, and the treatment of anxiety-based disorders. J Clin Psychol 1979; 35: 840-843.
186. McGlynn FD, Williamson LM, Davis DJ. Semi-automated desensitization as a treatment for genuinely fearful subjects. Behav Res Ther 1973; 11: 313-315.
187. Beiman I, Israel E, Johnson SA. During training and posttraining effects of live and taped extended progressive relaxation, self-relaxation, and electromyogram biofeedback. J Consult Clin Psychol 1978; 46: 314-321.
188. Norton GR, Johnson WE. A comparison of two relaxation procedures for reducing cognitive and somatic anxiety. J Behav Ther Exp Psychiatry 1983; 14: 209-214.
189. Rachman S. Studies in desensitization: I. The separate effects of relaxation and desensitization. Behav Res Ther 1965; 3: 245-251.
190. Lanyon RI, Manosevitz M, Imber RR. Systematic desensitization: distribution of practice and symptom substitution. Behav Res Ther 1968; 6: 323-329.
191. Gilroy LJ, Kirkby KC, Daniels BA, et al. Controlled comparison of computer-aided vicarious exposure versus live exposure in the treatment of spider phobia. Behav Ther 2000; 31: 733-744.
192. Ost LG, Johansson J, Jerremalm A. Individual response patterns and the effects of different behavioural methods in the treatment of claustrophobia. Behav Res Ther 1982; 20: 445-460.
193. Ost LG, Lindahl IL, Sterner U, Jerremalm A. Exposure in vivo vs applied relaxation in the treatment of blood phobia. Behav Res Ther 1984; 22: 205-216.
194. Ost LG, Sterner U, Fellenius J. Applied tension, applied relaxation, and the combination in the treatment of blood phobia. Behav Res Ther 1989; 27: 109-121.
195. Gatchel RJ, Hatch JP, Watson PJ, et al. Comparative effectiveness of voluntary heart rate control and muscular relaxation as active coping skills for reducing speech anxiety. J Consult Clin Psychol 1977; 45: 1093-1100.
196. Russell RK. The use of systematic desensitization and conditioned relaxation in the treatment of public speaking anxiety [dissertation]. Chicago: University of Illinois, 1972.
197. Trexler LD, Karst TO. Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. J Abnorm Psychol 1972; 79: 60-67.
198. Gross RT, Fremouw WJ. Cognitive restructuring and progressive relaxation for treatment of empirical subtypes of speech-anxious subjects. Cognit Ther Res 1982; 6: 429-436.
199. Goldfried MR, Trier CS. Effectiveness of relaxation as an active coping skill. J Abnorm Psychol 1974; 83: 348-355.
200. Spector IP, Carey MP, Jorgensen RS, et al. Cue-controlled relaxation and "aromatherapy" in the treatment of speech anxiety. Behav Psychother 1993; 21: 239-253.
201. Osberg JW. The effectiveness of applied relaxation in the treatment of speech anxiety. Behav Ther 1981; 12: 723-729.
202. Plotkin DP. The effects of interoceptive exposure on fear reduction and return of fear in individuals with public speaking anxiety [dissertation]. Los Angeles: University of California, 2001.
203. Laxer RM, Quarter J, Kooman A, Walker K. Systematic desensitization and relaxation of high-test-anxious secondary school students. J Counseling Psychol 1969; 16: 446-451.
204. Laxer RM, Walker K. Counterconditioning versus relaxation in the desensitization of test anxiety. J Counseling Psychol 1970; 17: 431-436.
205. Russell RK, Wise F, Stratoudakis JP. Treatment of test anxiety by cue-controlled relaxation and systematic desensitization. J Counseling Psychol 1976; 23: 563-566.
206. Chang-Liang R, Denney DR. Applied relaxation as training in self-control. J Counseling Psychol 1976; 23: 183-189.
207. McGlynn FD, Kinjo K, Doherty G. Effects of cue-controlled relaxation, a placebo treatment, and no treatment on changes in self-reported test anxiety among college students. J Clin Psychol 1978; 34: 707-714.
208. Baither RC, Godsey R. Rational emotive education and relaxation training in large group treatment of test anxiety. Psychol Rep 1979; 45: 326.
209. Hahnloser RM. A comparison of cognitive restructuring and progressive relaxation in test anxiety reduction [dissertation]. Eugene: University of Oregon, 1974.
210. Denney DR. Active, passive, and vicarious desensitization. J Counseling Psychol 1974; 21: 369-375.
211. Katz B. Treatment of test anxious students by rational-emotive therapy, relaxation placebo and no-treatment [dissertation]. Salt Lake City: University of Utah, 1977.
212. Jenkins SA. The relative efficacy of two treatment procedures in modifying maladaptive response systems in the high test anxious student [dissertation]. Bloomington: Indiana University, 1977.
213. Johnson DL. The relative efficacy of cue-controlled relaxation therapy, pseudotherapy, and no-treatment control on psychometric and psychophysiological measures of test anxiety [dissertation]. Blacksburg: Virginia Polytechnic Institute and State University, 1977.
214. Schafer NB. Differential treatment of test anxiety utilizing group systematic desensitization and relaxation training [dissertation]. Muncie, Ind: Ball State University, 1971.
215. Counts DK, Hollandsworth JG, Alcorn JD. Use of electromyographic biofeedback and cue-controlled relaxation in the treatment of test anxiety. J Consult Clin Psychol 1978; 46: 990-996.
216. Barrios BA, Ginter EJ, Scalise JJ, Miller FG. Treatment of test anxiety by applied relaxation and cue-controlled relaxation. Psychol Rep 1980; 46: 1287-1296.
217. Russell RK, Lent RW. Cue-controlled relaxation and systematic desensitization versus nonspecific factors in treating test anxiety. J Counseling Psychol 1982; 29: 100-103.
218. Sherman AR, Mulac A, McCann MJ. Synergistic effect of self-relaxation and rehearsal feedback in the treatment of subjective and behavioral dimensions of speech anxiety. J Consult Clin Psychol 1974; 42: 819-827.
219. Snyder AL, Deffenbacher JL. Comparison of relaxation as self-control and systematic desensitization in the treatment of test anxiety. J Consult Clin Psychol 1977; 45: 1202-1203.
220. Deffenbacher JL, Mathis H, Michaels AC. Two self-control procedures in the reduction of targeted and nontargeted anxieties. J Counseling Psychol 1979; 26: 120-127.
221. Marchetti A, McGlynn FD, Patterson AS. Effects of cue-controlled relaxation, a placebo treatment, and no treatment on changes in self-reported and psychophysiological indices of test anxiety among college students. Behav Modif 1977; 1: 47-72.
222. Kirkland K, Hollandsworth JG. Effective test taking: skills-acquisition versus anxiety-reduction techniques. J Consult Clin Psychol 1980; 48: 431-439.
223. Freeling NW, Shemberg KM. The alleviation of test anxiety by systematic desensitization. Behav Res Ther 1970; 8: 293-299.
224. Aponte JF, Aponte CE. Group preprogrammed systematic desensitization without the simultaneous presentation of aversive scenes with relaxation training. Behav Res Ther 1971; 9: 337-346.
225. Ricketts MS, Galloway RE. Effects of three different one-hour single session treatments for test anxiety. Psychol Rep 1984; 54: 115-120.
226. Johnson SM, Sechrest L. Comparison of desensitization and progressive muscle relaxation in treating test anxiety. J Consult Clin Psychol 1968; 32: 280-286.
227. Broota A, Sanghvi C. Efficacy of two relaxation techniques in examination anxiety. Special section: relaxation techniques and psychological management. J Pers Clin Studies 1994; 10: 29-35.
228. Comer JF. Meditation and progressive relaxation in the treatment of test anxiety [dissertation]. Lawrence: University of Kansas, 1977.
229. Bedell JR. Systematic desensitization, relaxation-training and suggestion in the treatment of test anxiety. Behav Res Ther 1975; 14: 309-311.
230. Mason TW. Treatment of test anxious students by applied cue-controlled relaxation, cue-controlled relaxation, applied relaxation, relaxation placebo and no-treatment [dissertation]. Lubbock: Texas Tech University, 1982.
231. Hurwitz LR, Kahane J, Mathieson C. The effect of EMG biofeedback and progressive muscle relaxation on the reduction of test anxiety. Educ Psychol Res 1986; 6: 291-298.
232. Sahasi G, Mohan D, Kacker C. Effectiveness of yogic techniques in the management of anxiety. J Personality Clin Stud 1989; 5: 51-55.
233. Castaneda R, Sussman N, Levy R, et al. A review of the effects of moderate alcohol intake on psychiatric and sleep disorders. Recent Dev Alcohol 1998; 14: 197-226.
234. Kushner MG, Abrams K, Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev 2000; 20: 149-171.
235. Kushner MG, Mackenzie TB, Fiszdon J, et al. The effects of alcohol consumption on laboratory-induced panic and state anxiety. Arch Gen Psychiatry 1996; 53: 264-270.
236. Abrams K, Kushner MG, Medina KL, Voight A. The pharmacologic and expectancy effects of alcohol on social anxiety in individuals with social phobia. Drug Alcohol Depend 2001; 64: 219-231.
237. MacDonald AB, Stewart SH, Hutson R, et al. The roles of alcohol and alcohol expectancy in the dampening of responses to hyperventilation among high anxiety sensitive young adults. Addict Behav 2001; 26: 841-867.
238. Lehman CL. Effects of alcohol consumption on laboratory-induced panic in patients with panic disorder: the role of alcohol outcome expectancy [dissertation]. Boston, Mass: Boston University, 2000.
239. Rimm D, Briddell D, Zimmerman M, Caddy G. The effects of alcohol and the expectancy of alcohol on snake fear. Addicit Behav 1981; 6: 47-51.
240. Himle JA, Abelson JL, Haghhightgou H, et al. Effect of alcohol on social phobic anxiety. Am J Psychiatry 1999; 156: 1237-1243.
241. Naftolowitz DF, Vaughn BV, Ranc J, Tancer ME. Response to alcohol in social phobia. Anxiety 1994; 1: 96-99.
242. Thyer BA, Curtis GC. The effects of ethanol intoxication on phobic anxiety. Behav Res Ther 1984; 22: 599-610.
243. Keane TM, Lisman SA. Alcohol and social anxiety in males: behavioral, cognitive, and physiological effects. J Abnorm Psychol 1980; 89: 213-223.
244. Thevos AK, Johnston AL, Latham PK, et al. Symptoms of anxiety in inpatient alcoholics with and without DSM-III-R anxiety diagnoses. Alcohol Clin Exp Res 1991; 15: 102-105.
245. Wetterling T, Junghanns K. Psychopathology of alcoholics during withdrawal and early abstinence. Eur Psychiatry 2000; 15: 483-488.
246. Liappas J, Paparrigopoulos T, Tzavellas E, Christodoulou G. Impact of alcohol detoxification on anxiety and depressive symptoms. Drug Alcohol Depend 2002; 68: 215-220.
247. Driessen M, Meier S, Hill A, et al. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol 2001; 36: 249-255.
248. Brown SA, Irwin M, Schuckit MA. Changes in anxiety among abstinent male alcoholics. J Stud Alcohol 1991; 52: 55-61.
249. Roberts MC, Emsley RA, Pienaar WP, Stein DJ. Anxiety disorders among abstinent alcohol-dependent patients. Psychiatr Serv 1999; 50: 1359-1361.
250. Uhde TW. Caffeine-induced anxiety: an ideal chemical model of panic disorder? In: Asnis GM, van Praag HM, editors. Panic disorder: clinical, biological, and treatment aspects. Detroit: Einstein Psychiatry, 1995: 181-205.
251. Bruce MS, Lader M. Caffeine abstention in the management of anxiety disorders. Psychol Med 1989; 19: 211-214.
252. Smith GA. Caffeine reduction as an adjunct to anxiety management. Br J Clin Psychol 1988; 27: 265-266.
253. Salzer MS, Berenbaum H. Somatic sensations, anxiety, and control in panic disorder. J Behav Ther Exp Psychiatry 1994; 25: 75-80.
254. Uhde TW. Caffeine provocation of panic: a focus on biological mechanisms. In: Ballenger JC, editor Neurobiological aspects of panic disorder New York: Alan Liss, 1990: 219-242.
255. Uhde TW, Boulenger JP, Jimerson DC, Post RM. Caffeine: relationship to human anxiety, plasma MHPG and cortisol. Psychopharmacol Bull 1984; 20: 426-430.
256. Boulenger JP, Uhde TW, Wolff EA, Post RM. Increased sensitivity to caffeine in patients with panic disorders: preliminary evidence. Arch Gen Psychiatry 1984; 41: 1067-1071.
257. Bruce M, Scott N, Shine P, Lader M. Anxiogenic effects of caffeine in patients with anxiety disorders. Arch Gen Psychiatry 1992; 49: 867-869.
258. Newman F, Stein MB, Trettau JR, et al. Quantitative electroencephalographic effects of caffeine in panic disorder. Psychiatry Res 1992; 45: 105-113.
259. Bond AJ, Shine P, Bruce M. Validation of visual analogue scales in anxiety. Int J Methods Psychiatr Res 1995; 5: 1-9.
260. Totten GL, France CR. Physiological and subjective anxiety responses to caffeine and stress in nonclinical panic. J Anxiety Disord 1995; 9: 473-488.
261. Beck GJ, Berisford AM. The effects of caffeine on panic patients: response components of anxiety. Behav Ther 1992; 23: 405-422.
262. Tancer ME, Stein MB, Uhde TW. Lactic acid response to caffeine in panic disorder: comparison with social phobics and normal controls. Anxiety 1994-95; 1: 138-140.
263. Davis DD, Dunlop SR, Shea P, et al. Biological stress responses in high and low trait anxious students. Biol Psychiatry 1985; 20: 843-851.
264. Lee MA, Cameron OG, Greden JF. Anxiety and caffeine consumption in people with anxiety disorders. Psychiatry Res 1985; 15: 211-217.
265. Markus CR, Panhuysen G, Jonkman LM, Bachman M. Carbohydrate intake improves cognitive performance of stress-prone individuals under controllable laboratory stress. Br J Nutr 1999; 82: 457-467.
266. Wurtman RJ. Nutrients affecting brain composition and behavior. Integr Psychiatry 1987; 5: 226-257.
267. Parrott AC. Nesbitt's Paradox resolved? Stress and arousal modulation in cigarette smoking. Addiction 1998; 93: 27-39.
268. Jarvik ME, Henningfield JE. Pharmacological treatment of tobacco dependence. Pharmacol Biochem Behav 1988; 30: 279-294.
269. Parrott AC. Stress modulation over the day in cigarette smokers. Addiction 1995; 90: 233-244.
270. West R, Hajek P. What happens to anxiety levels on giving up smoking? Am J Psychiatry 1997; 154: 1589-1592.
271. Parker G, Hadzi-Pavolvic D. Is any female preponderance in depression secondary to a primary female preponderance in anxiety disorders? Acta Psychiatr Scand 2001; 103: 252-256.